FILE - This Thursday, Dec. 21, 2017 file photo shows the MedMen marijuana dispensary in Los Angeles. Marijuana stocks have come down hard from their highs a year ago, and the skid isn't just spooking investors. On Tuesday, Oct. 8, 2019, MedMen Enterprises Inc., which sells legal cannabis in California and 11 other states, backed out of a blockbuster deal to buy PharmaCann, a Chicago-based marijuana company with operations in eight states. (AP Photo/Richard Vogel, File)

MedMen's ends blockbuster deal adding to cannabis stock woes

October 08, 2019 - 8:31 pm

LOS ANGELES (AP) — Marijuana stocks have come down hard from their highs a year ago, and the skid isn't just spooking investors.

On Tuesday, MedMen Enterprises Inc., which sells legal cannabis in California and 11 other states, backed out of a blockbuster deal to buy PharmaCann, a Chicago-based marijuana company with operations in eight states.

In its announcement, Los Angeles-based MedMen cited the steep pullback in U.S. and Canadian cannabis stocks this year, noting the Horizons Marijuana Life Sciences Index, a Canadian exchange-traded fund that tracks cannabis stocks, is down 47% since March.

AP Editorial Categories: